206 related articles for article (PubMed ID: 37248411)
1. Chemoproteomics reveals microbiota-derived aromatic monoamine agonists for GPRC5A.
Zhao X; Stein KR; Chen V; Griffin ME; Lairson LL; Hang HC
Nat Chem Biol; 2023 Oct; 19(10):1205-1214. PubMed ID: 37248411
[TBL] [Abstract][Full Text] [Related]
2. Differential In Vitro Pharmacological Profiles of Structurally Diverse Nociceptin Receptor Agonists in Activating G Protein and Beta-Arrestin Signaling at the Human Nociceptin Opioid Receptor.
Lu JJ; Polgar WE; Mann A; Dasgupta P; Schulz S; Zaveri NT
Mol Pharmacol; 2021 Jul; 100(1):7-18. PubMed ID: 33958480
[TBL] [Abstract][Full Text] [Related]
3. Elucidating structural and molecular mechanisms of β-arrestin-biased agonism at GPCRs via MS-based proteomics.
Xiao K; Sun J
Cell Signal; 2018 Jan; 41():56-64. PubMed ID: 28939107
[TBL] [Abstract][Full Text] [Related]
4. [Biased Signaling through G Protein-coupled Receptors].
Kurose H
Yakugaku Zasshi; 2022; 142(10):1091-1101. PubMed ID: 36184444
[TBL] [Abstract][Full Text] [Related]
5. Screening β-arrestin recruitment for the identification of natural ligands for orphan G-protein-coupled receptors.
Southern C; Cook JM; Neetoo-Isseljee Z; Taylor DL; Kettleborough CA; Merritt A; Bassoni DL; Raab WJ; Quinn E; Wehrman TS; Davenport AP; Brown AJ; Green A; Wigglesworth MJ; Rees S
J Biomol Screen; 2013 Jun; 18(5):599-609. PubMed ID: 23396314
[TBL] [Abstract][Full Text] [Related]
6. Substance P Serves as a Balanced Agonist for MRGPRX2 and a Single Tyrosine Residue Is Required for β-Arrestin Recruitment and Receptor Internalization.
Chompunud Na Ayudhya C; Amponnawarat A; Ali H
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34070125
[TBL] [Abstract][Full Text] [Related]
7. A novel luminescence-based β-arrestin recruitment assay for unmodified receptors.
Hauge Pedersen M; Pham J; Mancebo H; Inoue A; Asher WB; Javitch JA
J Biol Chem; 2021; 296():100503. PubMed ID: 33684444
[TBL] [Abstract][Full Text] [Related]
8. Characterization of structurally novel G protein biased CB
Ford BM; Franks LN; Tai S; Fantegrossi WE; Stahl EL; Berquist MD; Cabanlong CV; Wilson CD; Penthala NR; Crooks PA; Prather PL
Pharmacol Res; 2017 Nov; 125(Pt B):161-177. PubMed ID: 28838808
[TBL] [Abstract][Full Text] [Related]
9. Chemoproteomic Analysis of Microbiota Metabolite-Protein Targets and Mechanisms.
Zhao X; Yang X; Hang HC
Biochemistry; 2022 Dec; 61(24):2822-2834. PubMed ID: 34989554
[TBL] [Abstract][Full Text] [Related]
10. Agonist-biased signaling at the histamine H4 receptor: JNJ7777120 recruits β-arrestin without activating G proteins.
Rosethorne EM; Charlton SJ
Mol Pharmacol; 2011 Apr; 79(4):749-57. PubMed ID: 21134907
[TBL] [Abstract][Full Text] [Related]
11. The bile acid receptor TGR5 does not interact with β-arrestins or traffic to endosomes but transmits sustained signals from plasma membrane rafts.
Jensen DD; Godfrey CB; Niklas C; Canals M; Kocan M; Poole DP; Murphy JE; Alemi F; Cottrell GS; Korbmacher C; Lambert NA; Bunnett NW; Corvera CU
J Biol Chem; 2013 Aug; 288(32):22942-60. PubMed ID: 23818521
[TBL] [Abstract][Full Text] [Related]
12. Agonist activation of the G protein-coupled receptor GPR35 involves transmembrane domain III and is transduced via Gα₁₃ and β-arrestin-2.
Jenkins L; Alvarez-Curto E; Campbell K; de Munnik S; Canals M; Schlyer S; Milligan G
Br J Pharmacol; 2011 Feb; 162(3):733-48. PubMed ID: 20958291
[TBL] [Abstract][Full Text] [Related]
13. Diindolylmethane Derivatives: Potent Agonists of the Immunostimulatory Orphan G Protein-Coupled Receptor GPR84.
Pillaiyar T; Köse M; Sylvester K; Weighardt H; Thimm D; Borges G; Förster I; von Kügelgen I; Müller CE
J Med Chem; 2017 May; 60(9):3636-3655. PubMed ID: 28406627
[TBL] [Abstract][Full Text] [Related]
14. High-throughput identification and characterization of novel, species-selective GPR35 agonists.
Neetoo-Isseljee Z; MacKenzie AE; Southern C; Jerman J; McIver EG; Harries N; Taylor DL; Milligan G
J Pharmacol Exp Ther; 2013 Mar; 344(3):568-78. PubMed ID: 23262279
[TBL] [Abstract][Full Text] [Related]
15. Molecular Mechanisms of Diverse Activation Stimulated by Different Biased Agonists for the β2-Adrenergic Receptor.
Chen J; Liu J; Yuan Y; Chen X; Zhang F; Pu X
J Chem Inf Model; 2022 Nov; 62(21):5175-5192. PubMed ID: 34802238
[TBL] [Abstract][Full Text] [Related]
16. Functional specialization of beta-arrestin interactions revealed by proteomic analysis.
Xiao K; McClatchy DB; Shukla AK; Zhao Y; Chen M; Shenoy SK; Yates JR; Lefkowitz RJ
Proc Natl Acad Sci U S A; 2007 Jul; 104(29):12011-6. PubMed ID: 17620599
[TBL] [Abstract][Full Text] [Related]
17. G Protein-Coupled Receptor Signaling Through β-Arrestin-Dependent Mechanisms.
Jean-Charles PY; Kaur S; Shenoy SK
J Cardiovasc Pharmacol; 2017 Sep; 70(3):142-158. PubMed ID: 28328745
[TBL] [Abstract][Full Text] [Related]
18. Detailed analysis of biased histamine H₄ receptor signalling by JNJ 7777120 analogues.
Nijmeijer S; Vischer HF; Sirci F; Schultes S; Engelhardt H; de Graaf C; Rosethorne EM; Charlton SJ; Leurs R
Br J Pharmacol; 2013 Sep; 170(1):78-88. PubMed ID: 23351115
[TBL] [Abstract][Full Text] [Related]
19. A Forward Chemical Genetic Screen Reveals Gut Microbiota Metabolites That Modulate Host Physiology.
Chen H; Nwe PK; Yang Y; Rosen CE; Bielecka AA; Kuchroo M; Cline GW; Kruse AC; Ring AM; Crawford JM; Palm NW
Cell; 2019 May; 177(5):1217-1231.e18. PubMed ID: 31006530
[TBL] [Abstract][Full Text] [Related]
20. Beta-arrestins as regulators of signal termination and transduction: how do they determine what to scaffold?
DeFea KA
Cell Signal; 2011 Apr; 23(4):621-9. PubMed ID: 20946952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
